Featured Articles

  1. Premier Perspective On Biomarkers In Oncology 11/2/2022

    Explore the common applications of biomarkers in oncology, with a focus on companion diagnostics and key considerations for incorporating biomarkers into clinical development programs.

  2. Enhancing Clinical Trial Accessibility: Bringing Oncology Trials To Patients 10/14/2022

    Today, proactively incorporating community clinicians and sites into clinical research is the next step in broadening the reach and diversity of oncology studies while still generating high-quality data. Listen to this podcast to find out more.

  3. Antibody-Drug Conjugates In Oncology: Key Considerations And Future Trends 10/13/2022

    In this blog, explore the current landscape of antibody-drug conjugates, including their benefits, limitations, key considerations for clinical trials, and potential future trends.

  4. Supporting Enrollment Of A Phase 2 Cervical Cancer Study During A Pandemic 10/13/2022

    The developer of an investigative medicinal product (IMP) for advanced, recurrent, non-resectable cervical cancer engaged Premier Research to assist with screening and enrollment in a Phase 2 study in Europe. Find out the results of this partnership.

  5. Maximizing Oncology Study Outcomes: Protocol Development Considerations 10/11/2022

    In this article, explore protocol development considerations to reduce patient burden and enhance the overall clinical trial experience.

  6. Real-World & Late Phase: Making The Switch From Rx To OTC 9/14/2022

    Given the right expertise, Rx-to-OTC conversions are easier to achieve with less time and expense than one might expect for a regulatory exercise.

  7. Patient Enrollment And Retention: Overcoming Challenges In Observational Research 9/14/2022

    Patient enrollment and retention for investigational trials are notoriously difficult. How is enrollment affected when there is no direct benefit to the patient? Find out here.

  8. 5 Strategies For Differentiating Trials In A Competitive Research Environment 9/12/2022

    Recruiting for rare disease trials has become even more challenging in recent years due to increasing competition in the clinical research environment. Delve into key challenges and explore strategies for differentiating trials in today’s competitive landscape.

  9. Understanding & Enhancing Natural History Studies' Value In Rare Diseases 9/12/2022

    Registry and natural history studies can be very important to the clinical development of therapeutics in rare diseases. To accommodate these advances in knowledge, study design flexibility is a must.

  10. 7 Tips For Designing & Operationalizing Uncommon Disease Studies 9/12/2022

    Explore seven tips on designing and operationalizing natural history studies to support successful rare disease therapeutic development.